The same group also synthesized novel Tau-targeting PROTACs, which preferentially degraded Tau in fronto-temporal dementia (FTD) neurons of frontotemporal dementia compared to normal cells [55]. The gene discussed is MAPT; the disease is frontotemporal dementia.